DER STANDARD veröffentlicht ausgesuchte Inhalte von The Economist im englischen Original (mehr dazu lesen Sie auf etat.at ).

Antidepressants help millions of people manage depression and other mental health conditions. They can improve mood, daily ...

The drug, called retatrutide, showed significant weight loss and improvements in a key measure of blood sugar levels.

Does a 3,500-calorie deficit equal a pound lost? Learn why scale weight is not pure fat loss and how to use dynamic planning ...

Novo Nordisk's lawsuit seeks a permanent injunction forcing Eli Lilly to pull the ads, as well as a corrective ad campaign.

As GLP-1 drug use surges nationwide, overall spending could soon drive up healthcare costs for everyone, according to a new ...

A new study reveals how next generation GIPR drugs act on the brainstem and hypothalamus to boost weight loss.

Model Camille Kostek addressed the "losers" who criticize her body online, putting the haters on blast in a TikTok video.

Sister’s rigid relationship with food and her resistance to talking about it worry the letter writer.

Eli Lilly will seek regulatory approval for retatrutide, a powerful weight loss drug that a new study shows helped people lose nearly 56 pounds on average.

In two new phase 3 clinical trials, the experimental GLP-1 drug also improved blood sugar, heart health metrics, and ...

Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two ...